Argenx
ARGX
#560
Rank
$36.14 B
Marketcap
$589.15
Share price
-0.73%
Change (1 day)
48.28%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of December 2024 : $39.05 Million USD

According to Argenx 's latest financial reports the company's total debt is $39.05 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2024-12-31$39.05 M95.27%
2023-12-31$20 M60.95%
2022-12-31$12.42 M8.38%
2021-12-31$11.46 M-3.48%
2020-12-31$11.87 M44.87%
2019-12-31$8.19 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31$2.95 M3.93%
2011-12-31$2.84 M